share_log

诚意药业(603811.SH):骨化三醇软胶囊获得药品注册证书

Zhejiang Cheng Yi Pharmaceutical (603811.SH): The calcitriol soft capsules have obtained the pharmaceutical registration certificate.

Gelonghui Finance ·  Jan 2 17:05

On January 2nd, Gelonghui reported that Zhejiang Cheng Yi Pharmaceutical (603811.SH) announced the receipt of the drug registration certificate for Calcifediol soft capsules approved by the National Medical Products Administration. Calcifediol soft capsules are clinically indicated for postmenopausal osteoporosis, chronic renal failure, especially for patients undergoing dialysis with renal osteodystrophy, postoperative hypoparathyroidism, idiopathic hypoparathyroidism, pseudohypoparathyroidism, vitamin D-dependent rickets, and hypophosphatemic vitamin D-resistant rickets, among others.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment